Harindranath Sidharth, Desai Devendra
Department of Gastroenterology, Seth GS medical college and KEM hospital, Mumbai, India.
Division of Gastroenterology, P.D Hinduja Hospital, Mumbai, India.
Expert Rev Med Devices. 2025 Jan-Feb;22(2):121-126. doi: 10.1080/17434440.2025.2453561. Epub 2025 Jan 15.
Wearables are electronic devices worn on the body to collect health data. These devices, like smartwatches and patches, use sensors to gather information on various health parameters. This review highlights the current use and the potential benefit of wearable technology in patients with inflammatory bowel disease (IBD).
In this review, we explore the current use of wearable technology in healthcare and the studies applying this technology in patients with IBD. We also discuss the limitations of using digital health data in general and wearable technology in particular in the current clinical paradigm and predict a path forward in how to rationally and effectively apply this technology to improve the care of patients with IBD. A comprehensive search of all suitable studies was conducted using the databases of PubMed, MEDLINE, Embase, and Scopus from inception to August 2024.
Currently, wearable technology is applied to the monitoring of IBD and prediction of flares using devices and sensors. Future applications include early disease detection using biosensors, advanced data collection through ingestible devices, gut microbiome monitoring, and integration with machine learning. These advancements promise to revolutionize disease management, including IBD, by enabling early diagnosis, personalized treatment, and improved patient outcomes.
可穿戴设备是穿戴在身体上用于收集健康数据的电子设备。这些设备,如智能手表和贴片,利用传感器收集各种健康参数的信息。本综述重点介绍了可穿戴技术在炎症性肠病(IBD)患者中的当前应用及潜在益处。
在本综述中,我们探讨了可穿戴技术在医疗保健中的当前应用以及将该技术应用于IBD患者的研究。我们还讨论了在当前临床模式下使用数字健康数据(特别是可穿戴技术)的局限性,并预测了如何合理有效地应用该技术以改善IBD患者护理的未来方向。使用PubMed、MEDLINE、Embase和Scopus数据库从创建到2024年8月对所有合适的研究进行了全面检索。
目前,可穿戴技术通过设备和传感器应用于IBD的监测和发作预测。未来的应用包括使用生物传感器进行疾病早期检测、通过可摄入设备进行高级数据收集、肠道微生物群监测以及与机器学习集成。这些进展有望通过实现早期诊断、个性化治疗和改善患者预后,彻底改变包括IBD在内的疾病管理。